T. Saeki

1.2k total citations
60 papers, 1.0k citations indexed

About

T. Saeki is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, T. Saeki has authored 60 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in T. Saeki's work include Cholesterol and Lipid Metabolism (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Diabetes Treatment and Management (7 papers). T. Saeki is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Diabetes Treatment and Management (7 papers). T. Saeki collaborates with scholars based in Japan, France and India. T. Saeki's co-authors include Isao Saito, Yasutaka Takase, Nobuyuki Yasuda, Kazuto Yamazaki, Isao Tanaka, Takashi Inoue, Tadashi Nagakura, Kazunobu Kira, Akihiro Ishii and Hiroshi Tanaka and has published in prestigious journals such as Physical Review Letters, Gastroenterology and Journal of Applied Physics.

In The Last Decade

T. Saeki

58 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Saeki Japan	19	450	261	238	214	108	60	1.0k
Korekiyo Wakitani Japan	17	331 0.7×	458 1.8×	339 1.4×	194 0.9×	86 0.8×	31	1.1k
Sampath Parthasarathy United States	10	257 0.6×	267 1.0×	207 0.9×	126 0.6×	47 0.4×	12	1.1k
Yoshimi Imura Japan	16	338 0.8×	188 0.7×	162 0.7×	99 0.5×	38 0.4×	31	1.0k
Kennan Marsh United States	10	848 1.9×	366 1.4×	183 0.8×	551 2.6×	86 0.8×	17	1.5k
Nobuyuki Negoro Japan	24	635 1.4×	478 1.8×	445 1.9×	334 1.6×	79 0.7×	44	1.5k
Dale E. Sharp United States	12	361 0.8×	324 1.2×	481 2.0×	57 0.3×	68 0.6×	13	878
Philip A. Carpino United States	20	414 0.9×	153 0.6×	123 0.5×	365 1.7×	39 0.4×	42	1.1k
Peter Eickelmann Germany	13	662 1.5×	408 1.6×	534 2.2×	68 0.3×	70 0.6×	19	1.0k
Peter S. Chan United States	19	690 1.5×	296 1.1×	59 0.2×	342 1.6×	90 0.8×	53	1.5k
K. W. M. Lawrie United Kingdom	10	380 0.8×	334 1.3×	135 0.6×	104 0.5×	58 0.5×	27	875

Countries citing papers authored by T. Saeki

Since Specialization

Citations

This map shows the geographic impact of T. Saeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Saeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Saeki more than expected).

Fields of papers citing papers by T. Saeki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Saeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Saeki. The network helps show where T. Saeki may publish in the future.

Co-authorship network of co-authors of T. Saeki

This figure shows the co-authorship network connecting the top 25 collaborators of T. Saeki. A scholar is included among the top collaborators of T. Saeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Saeki. T. Saeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saeki, T., et al.. (2009). Dose-Response Profile of PF-03187207 (PF-207) and Peak IOP Lowering Response Following Single Topical Administration to FP Receptor Knockout Mice vs. Wild Type Mice. Investigative Ophthalmology & Visual Science. 50(13). 4064–4064. 14 indexed citations

Yamazaki, Kazuto, Nobuyuki Yasuda, Takashi Inoue, et al.. (2006). 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one Is a Novel Competitive and Selective Inhibitor of Dipeptidyl Peptidase IV with an Antihyperglycemic Activity. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1253–1257. 12 indexed citations

Yamazaki, Kazuto, Nobuyuki Yasuda, Takashi Inoue, et al.. (2006). Effects of the Combination of a Dipeptidyl Peptidase IV Inhibitor and an Insulin Secretagogue on Glucose and Insulin Levels in Mice and Rats. Journal of Pharmacology and Experimental Therapeutics. 320(2). 738–746. 14 indexed citations

Yasuda, Nobuyuki, Takashi Inoue, Tadashi Nagakura, et al.. (2004). Metformin Causes Reduction of Food Intake and Body Weight Gain and Improvement of Glucose Intolerance in Combination with Dipeptidyl Peptidase IV Inhibitor in Zucker fa/fa Rats. Journal of Pharmacology and Experimental Therapeutics. 310(2). 614–619. 53 indexed citations

Yanagimachi, Mamoru, Masashi Ito, Nobuyuki Yasuda, et al.. (2003). Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. Journal of Lipid Research. 44(1). 128–135. 38 indexed citations

Yasuda, Nobuyuki, Takashi Inoue, Tadashi Nagakura, et al.. (2002). Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. Biochemical and Biophysical Research Communications. 298(5). 779–784. 119 indexed citations

Yanagimachi, Mamoru, Masashi Ito, T. Saeki, et al.. (2001). Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism. European Journal of Pharmacology. 431(3). 345–352. 27 indexed citations

Yanagimachi, Mamoru, et al.. (2000). Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Journal of Lipid Research. 41(7). 1136–1144. 53 indexed citations

Bardelle, Catherine, Caroline Smales, Masashi Ito, et al.. (1999). Phosphodiesterase 4 Conformers: Preparation of Recombinant Enzymes and Assay for Inhibitors. Analytical Biochemistry. 275(2). 148–155. 12 indexed citations

10.

Tanaka, Hiroshi, Hiroko Kobayashi, T. Saeki, et al.. (1996). Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 124(2). 203–210. 10 indexed citations

11.

Saeki, T., et al.. (1995). A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery.. Journal of Pharmacology and Experimental Therapeutics. 272(2). 825–831. 59 indexed citations

12.

Adachi, Hideyuki, T. Saeki, Nobuyuki Mori, & Isao Saito. (1994). CARDIOHEMODYNAMIC EFFECTS OF A NOVEL SELECTIVE AND POTENT PHOSPHODIESTERASE V INHIBITOR, E4021, IN THE PIG. Japanese Circulation Journal-english Edition. 58(7). 456. 1 indexed citations

13.

Takase, Yasutaka, et al.. (1994). Cyclic GMP Phosphodiesterase Inhibitors. 2. Requirement of 6-Substitution of Quinazoline Derivatives for Potent and Selective Inhibitory Activity. Journal of Medicinal Chemistry. 37(13). 2106–2111. 89 indexed citations

14.

Kimura, Teiji, et al.. (1993). Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy]phenyl]-N'-pentylurea and analogs. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity. Journal of Medicinal Chemistry. 36(11). 1630–1640. 20 indexed citations

15.

Takase, Yasutaka, T. Saeki, Masayuki Fujimoto, & Isao Saito. (1993). Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-[[3,4-(methylenedioxy)benzyl]amino]-6,7,8-trimethoxyquinazoline. Journal of Medicinal Chemistry. 36(24). 3765–3770. 27 indexed citations

16.

Saeki, T., et al.. (1991). A new anti-platelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets.. The Japanese Journal of Pharmacology. 55(1). 81–91. 6 indexed citations

17.

Saeki, T., et al.. (1990). Inhibitory effects of a novel antiatheromatous agent, E5050, an aortic smooth muscle cell proliferation, in vitro. European Journal of Pharmacology Molecular Pharmacology. 189(1). 23–29. 2 indexed citations

18.

Katagiri, Yoshihiro, et al.. (1985). Literature survey on the frequency of adverse reactions to chenodeoxycholic acid.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 16(2). 385–392. 1 indexed citations

19.

Saeki, T., et al.. (1984). PHOTOSTABILITY OF MECOBALAMIN IN TABLET AND CAPSULE AT THE DISPENSING LEVEL. 8(1). 1–8. 1 indexed citations

20.

Ogata, Masana, T. Saeki, Shohei Kira, Toru Hasegawa, & Shosuke Watanabe. (1974). DISTRIBUTION OF TOLUENE IN MOUSE TISSUES. Sangyo Igaku. 16(1). 23–25. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact